BMJ Files IPO Prospectus to Advance Evidence-Based Clinical Decision Support Systems and Empower Primary Care Transformation

Medical journals serve as vital platforms for disseminating the latest medical findings and are a key channel for researchers to stay abreast of global research advancements. The British Medical Journal (The BMJ) is highly esteemed within the medical community for its substantial influence and authority, reflecting cutting-edge developments in medical research.

The BMJ was founded in 1840 by the BMJ Publishing Group (hereinafter referred to as BMJ). After more than 170 years of development, The BMJ has become one of the world’s most prestigious top-tier general medical journals, and BMJ has emerged as a globally renowned non-profit organization dedicated to the publication and dissemination of medical knowledge.

On September 5, 2019, BMJ participated in the “China-UK Joint Innovation Exchange on Primary Healthcare and the Big Health Industry Cooperation Summit.” Moving forward, it will collaborate with Wuhou District in Chengdu, leveraging various evidence-based medicine resources under the BMJ umbrella—including clinical decision support systems—to help Wuhou District explore and build the next generation of primary healthcare service systems.

BMJ is affiliated with the British Medical Association, one of the world’s oldest medical associations.

The BMJ’s flagship journal, The BMJ (formerly the British Medical Journal), was founded in 1840 and is one of the most influential and innovative general medical journals worldwide. In 2018, its impact factor was 27.604. Additionally, BMJ Group publishes more than 70 world-class medical journals covering fields such as general medicine, specialties, epidemiology, pharmaceuticals, medical records, medical education, evidence-based medicine, and health. Nearly half of these journals are ranked in Q1 within their respective fields.

Ms. Kong Yuyan, Managing Director of BMJ China, stated, “One of the functions of BMJ Group is to serve physicians, whose needs extend beyond medical journals. Therefore, the Group’s business has naturally expanded beyond the publication of medical journals.”

Currently, BMJ’s business areas also include clinical decision support, medical education and training, and healthcare quality and safety. The Group’s products and services are available in more than 160 countries worldwide.

Among these, BMJ Learning now offers over 1,000 case-based interactive learning modules in 10 languages for healthcare professionals; BMJ Case Reports, the world’s largest single repository of clinical cases, contains tens of thousands of case reports; and BMJ Quality, a quality and safety improvement platform, won two gold awards related to online learning upon its launch.

To better serve and participate in the development of China’s healthcare sector, BMJ China was officially established in 2015, becoming the third independently operated overseas center after BMJ North America and BMJ India.

Ms. Kong pointed out, “Medical knowledge, like diseases, knows no borders. China, home to one-fifth of the global population, is a vital part of the world and exerts significant influence on global health development.” Currently, BMJ’s operations in China primarily focus on medical journal publishing, clinical decision support, and medical training and education. “In the near future, the Group will bring more of its business activities to China.”

BMJ is a proponent and promoter of evidence-based medicine. Since publishing the world’s first randomized controlled clinical trial in 1949, BMJ has not only published the classic definition of evidence-based medicine and launched evidence-based medicine journals, but also led discussions and advancements in the field.

With the various developments in evidence-based medicine (EBM) research and digital publishing, BMJ has increasingly prioritized the promotion of EBM in clinical practice since the 1990s. In 1999, BMJ began publishing BMJ Clinical Evidence, an EBM evidence repository. Building on this foundation, it launched BMJ Best Practice (hereinafter referred to as BP), an EBM clinical decision support system, in 2009. These world-class EBM resources represent a significant innovation and leap forward by translating the latest medical research evidence into knowledge tools that can directly guide clinical practice.

BP synthesizes diagnostic and therapeutic knowledge that is prudent, concise, directly actionable for clinical decision-making, and supported by traceable evidence, based on the latest global evidence and expert experience in accordance with evidence-based medicine methodologies. It is updated in a timely manner to provide immediate support for clinicians in adopting appropriate and safe diagnostic and treatment approaches, thereby helping to reduce medical errors, lower healthcare costs, and improve patient outcomes.

After more than two decades of effort, BP now covers 32 clinical specialties and nearly 90% of known common diseases. Translated into seven languages, it provides comprehensive support for the entire care continuum—including prevention, diagnosis, treatment, follow-up, and patient education—to physicians worldwide.

In an independent international evaluation of clinical decision support systems conducted in 2016, BP ranked first (including ties) across key assessment metrics such as disease coverage, editorial quality, and evidence-based methodology. The evaluation report was published in the Journal of Medical Internet Research, the top-ranked specialty journal in the field of medical informatics.

After years of effort, BMJ collaborated with nearly 1,000 Chinese experts from the Chinese Medical Association to launch the Chinese version of Best Practice (BP) in 2016. It translates the entire BP database into Chinese and provides real-time updates, making it the first international evidence-based clinical decision support system to offer a fully Chinese-language version.

Subsequently, BMJ rolled out various application formats for the Chinese version of BP, making it the first fully Chinese, multidisciplinary, evidence-based clinical decision support system accessible via web portal, mobile app, and intelligent integration with electronic medical records.

At the end of 2018, BMJ collaborated with Peking University Third Hospital to complete the integrated application combining BMJ Best Practice (BP) with local clinical big data. This initiative created a clinical decision support system based on a dual-engine foundation of evidence-based medicine guidelines and real-world clinical data, marking a first in China. A retrospective study conducted six months later showed that the implementation of this system significantly improved the efficiency and accuracy of physicians’ diagnostic and treatment decisions, while further reducing the average length of hospital stays for patients.

On September 5, 2019, the “China-UK Joint Innovation Exchange Conference on Primary Healthcare and the Big Health Industry Cooperation Summit,” hosted by the People’s Government of Wuhou District, Chengdu, was held in Wuhou District.

Ms. Kong stated at the conference, “Benefiting from the rapid development of the healthcare system and digitalization, primary healthcare institutions in China have acquired or will acquire favorable policies and resources, thereby assuming greater responsibilities in delivering health services. The overall enhancement of clinical competencies among primary care physicians is the most critical factor in translating these policies and resources into high-quality service delivery. Credible, efficient, and digitally enabled training, clinical decision support, and management tools are essential means to help primary care physicians comprehensively and rapidly improve their diagnostic and therapeutic capabilities. BMJ looks forward to collaborating with more health authorities and professional organizations to jointly advance the development of primary healthcare in China.”